Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor
Reggie Bosma(Vrije Universiteit Amsterdam), Rob Leurs(Vrije Universiteit Amsterdam), Victoria Georgi(Bayer (Germany)), Nick Bushby(AstraZeneca (United Kingdom)), Stephen J. Hill(University of Nottingham), Henry F. Vischer(Vrije Universiteit Amsterdam), Mónica Bouzo-Lorenzo(Complejo Hospitalario Universitario de Santiago), Michael J. Waring(Newcastle University), Leigh A. Stoddart(University of Glasgow), Stephen J. Briddon(University of Nottingham), Amaury E. Fernández‐Montalván(Bayer (Germany)), Robert J. Sheppard(AstraZeneca (Sweden)), Loretta Inkoom(Vrije Universiteit Amsterdam)
Cited by 24
Related Papers
An analysis of the attrition of drug candidates from four major pharmaceutical companies
|Nature Reviews Drug Discovery|2015|1.4k
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Agonist and Inverse Agonist Actions of β-Blockers at the Human β2-Adrenoceptor Provide Evidence for Agonist-Directed Signaling
|Molecular Pharmacology|2003|187
The p85 Subunit of Phosphatidylinositol 3-Kinase Associates with the Fc Receptor γ-Chain and Linker for Activitor of T Cells (LAT) in Platelets Stimulated by Collagen and Convulxin
|Journal of Biological Chemistry|1998|145
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling
|Trends in Pharmacological Sciences|2011|134